|
1
|
Bhowmick NA and Moses HL: Tumor-stroma
interactions. Curr Opin Genet Dev. 15:97–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim JB, Stein R and O'Hare MJ:
Tumour-stromal interactions in breast cancer: The role of stroma in
tumourigenesis. Tumour Biol. 26:173–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tlsty TD and Coussens LM: Tumor stroma and
regulation of cancer development. Annu Rev Pathol. 1:119–150. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olumi AF, Grossfeld GD, Hayward SW,
Carroll PR, Tlsty TD and Cunha GR: Carcinoma-associated fibroblasts
direct tumor progression of initiated human prostatic epithelium.
Cancer Res. 59:5002–5011. 1999.PubMed/NCBI
|
|
5
|
Nagasaki T, Hara M, Nakanishi H, Takahashi
H, Sato M and Takeyama H: Interleukin-6 released by colon
cancer-associated fibroblasts is critical for tumour angiogenesis:
Anti-interleukin-6 receptor antibody suppressed angiogenesis and
inhibited tumour-stroma interaction. Br J Cancer. 110:469–478.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu J, Chen S, Wang W, Ning BF, Chen F,
Shen W, Ding J, Chen W, Xie WF and Zhang X: Cancer-associated
fibroblasts promote hepatocellular carcinoma metastasis through
chemokine-activated hedgehog and TGF-β pathways. Cancer Lett.
379:49–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Straussman R, Morikawa T, Shee K,
Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J,
Frederick DT, et al: Tumour micro-environment elicits innate
resistance to RAF inhibitors through HGF secretion. Nature.
487:500–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kurose K, Gilley K, Matsumoto S, Watson
PH, Zhou XP and Eng C: Frequent somatic mutations in PTEN and TP53
are mutually exclusive in the stroma of breast carcinomas. Nat
Genet. 32:355–357. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wernert N, Locherbach C, Wellmann A,
Behrens P and Hügel A: Presence of genetic alterations in
microdissected stroma of human colon and breast cancers. Anticancer
Res. 21:2259–2264. 2001.PubMed/NCBI
|
|
10
|
Paterson RF, Ulbright TM, MacLennan GT,
Zhang S, Pan CX, Sweeney CJ, Moore CR, Foster RS, Koch MO, Eble JN
and Cheng L: Molecular genetic alterations in the
laser-capture-microdissected stroma adjacent to bladder carcinoma.
Cancer. 98:1830–1836. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akahane T, Hirasawa A, Tsuda H, Kataoka F,
Nishimura S, Tanaka H, Tominaga E, Nomura H, Chiyoda T, Iguchi Y,
et al: The origin of stroma surrounding epithelial ovarian cancer
cells. Int J Gynecol Pathol. 32:26–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tuhkanen H, Anttila M, Kosma VM, Heinonen
S, Juhola M, Helisalmi S, Kataja V and Mannermaa A: Frequent gene
dosage alterations in stromal cells of epithelial ovarian
carcinomas. Int J Cancer. 119:1345–1353. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Permuth-Wey J and Sellers TA: Epidemiology
of ovarian cancer. Methods Mol Biol. 472:413–437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McConechy MK, Ding J, Senz J, Yang W,
Melnyk N, Tone AA, Prentice LM, Wiegand KC, McAlpine JN, Shah SP,
et al: Ovarian and endometrial endometrioid carcinomas have
distinct CTNNB1 and PTEN mutation profiles. Mod Pathol. 27:128–134.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murakami R, Matsumura N, Brown JB, Higasa
K, Tsutsumi T, Kamada M, Abou-Taleb H, Hosoe Y, Kitamura S,
Yamaguchi K, et al: Exome sequencing landscape analysis in ovarian
clear cell carcinoma shed light on key chromosomal regions and
mutation gene networks. Am J Pathol. 187:2246–2258. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y,
Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et
al: ARID1A mutations in endometriosis-associated ovarian
carcinomas. N Engl J Med. 363:1532–1543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SI, Lee JW, Lee M, Kim HS, Chung HH,
Kim JW, Park NH, Song YS and Seo JS: Genomic landscape of ovarian
clear cell carcinoma via whole exome sequencing. Gynecol Oncol.
148:375–382. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scully RE YR and Clement PB: Tumors with
functioning stroma. Tumors of the ovary, maldeveloped gonads,
fallopian tube and broad ligament. In: Atlas of Tumor Pathology
Armed Forces Institute of Pathology; Washington, DC: pp. pp373–378.
1998
|
|
19
|
Kato N, Hayasaka T, Takeda J, Osakabe M
and Kurachi H: Ovarian tumors with functioning stroma: A
clinicopathologic study with special reference to serum estrogen
level, stromal morphology and aromatase expression. Int J Gynecol
Pathol. 32:556–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katoh T, Yasuda M, Hasegawa K, Kozawa E,
Maniwa J and Sasano H: Estrogen-producing endometrioid
adenocarcinoma resembling sex cord-stromal tumor of the ovary: A
review of four postmenopausal cases. Diagn Pathol. 7:1642012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stewart CJ, Leung Y, Walsh MD, Walters RJ,
Young JP and Buchanan DD: KRAS mutations in ovarian low-grade
endometrioid adenocarcinoma: Association with concurrent
endometriosis. Hum Pathol. 43:1177–1183. 2012. View Article : Google Scholar : PubMed/NCBI
|
